Skip to content
Acceleron Pharma

Investors/Media

Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Aug 1, 2007
Pharmaceutical Executive, August 1, 2007
Jul 31, 2007
CAMBRIDGE, MA – July 31, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel biotherapeutics, today announced that company President and Founder, John Knopf, Ph.D., will provide a corporate presentation at the 27th Annual Canaccord Adams Global Growth Conference on Tuesday August 7, 2007 at 1:30 pm ...
Jul 16, 2007
Link to article
Jun 26, 2007
Kos, Greece – June 26, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced results demonstrating that ACE-011, a novel anabolic bone agent for the treatment of bone loss, preserved bone mass and...
Jun 1, 2007
Start-Up: June 1, 2007
May 14, 2007
LUCCA, ITALY – May 14, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced results of a preclinical study with ACE-031 that demonstrated the ability of the compound to increase muscle mass and s...
Apr 25, 2007
CAMBRIDGE, MA – April 25, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced the appointment of James Desiderio, Ph.D. as Vice President, Program Management.. “The Acceleron pro...
Apr 1, 2007
Link to article
Mar 29, 2007
CAMBRIDGE, MA – March 29, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced the appointment of Robert Steininger as Senior Vice President, Manufacturing. “Acceleron is rapidly advancing and ...
Mar 7, 2007
CAMBRIDGE, MA – March 7, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel biotherapeutics, today announced that Steven Ertel, Vice President Business Development, will provide a corporate presentation at the Cowen and Company 27th Annual Health Care Conference on Thursday March 15, 2007 at 9:30...
Nov 3, 2006
CAMBRIDGE, MA – November 3, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company developing regenerative therapeutics, today announced that Glenn Batchelder, Chief Executive Officer, will provide a corporate presentation at the Rodman & Renshaw 8th Annual Healthcare Conference on Monday, November 6, 2006 at 4:55 p.m. (EST)....
Oct 30, 2006
CAMBRIDGE, MA – October 30, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, today announced that Glenn Batchelder, Chief Executive Officer, will provide a corporate presentation at the Massachusetts Biotechnology Council’s MASS Opportunities Conference on Thur...
Sep 18, 2006
CAMBRIDGE, MA – September 18, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, presented preclinical data highlighting the anabolic bone activity of ACE-011, the company’s lead drug candidate currently in a phase 1 clinical trial, at the Annual Meeting of the A...
Sep 12, 2006
CAMBRIDGE, MA – September 12, 2006 – Acceleron Pharma, Inc., a biopharmaceutical company involved in the development of regenerative therapeutics, announced that it will present preclinical data highlighting the anabolic bone activity of ACE-011, the company’s lead drug candidate and a novel treatment for bone loss, at the Annu...
Aug 21, 2006
Red Herring, August 21, 2006
= add release to Briefcase